These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 26509390)

  • 1. Prophylactic Use of Antiemetics for Prevention of Opioid-Induced Nausea and Vomiting: A Questionnaire Survey among Japanese Physicians.
    Tsukuura H; Ando Y; Gyawali B; Matsumoto M; Sugishita M; Honda K; Urakawa H; Maeda O; Hasegawa Y
    J Palliat Med; 2015 Nov; 18(11):977-80. PubMed ID: 26509390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic use of antiemetics for prevention of opioid-induced nausea and vomiting: a survey about Italian physicians' practice.
    Giusti R; Mazzotta M; Filetti M; Daniele G; Tsukuura H; Ficorella C; Porzio G; Marchetti P; Verna L
    Support Care Cancer; 2019 Sep; 27(9):3531-3535. PubMed ID: 30684048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Prophylactic Treatment for Oxycodone-Induced Nausea and Vomiting Among Patients with Cancer Pain (POINT): A Randomized, Placebo-Controlled, Double-Blind Trial.
    Tsukuura H; Miyazaki M; Morita T; Sugishita M; Kato H; Murasaki Y; Gyawali B; Kubo Y; Ando M; Kondo M; Yamada K; Hasegawa Y; Ando Y
    Oncologist; 2018 Mar; 23(3):367-374. PubMed ID: 29038236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological treatment of cancer pain and opioid induced nausea and vomiting: online survey and comparison with current guidelines.
    Gaertner J; Boehlke C; Kreye G; Fusi-Schmidhauser T; Mueller E; Roch C
    Support Care Cancer; 2024 Jun; 32(7):436. PubMed ID: 38879720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of nausea and vomiting induced by oxycodone administered with prochlorperazine in Japanese cancer patients.
    Yamada T; Kanazawa Y; Aoki Y; Uchida E
    J Nippon Med Sch; 2015; 82(2):100-5. PubMed ID: 25959201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic antiemetics for adults receiving intravenous opioids in the acute care setting.
    Gottlieb M; Carlson JN; Peksa GD
    Cochrane Database Syst Rev; 2022 May; 5(5):CD013860. PubMed ID: 35588093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors for nausea or vomiting in patients with cancer who receive oral oxycodone for the first time: is prophylactic medication for prevention of opioid-induced nausea or vomiting necessary?
    Kanbayashi Y; Hosokawa T
    J Palliat Med; 2014 Jun; 17(6):683-7. PubMed ID: 24702605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical interventions facilitate premedication and prevent opioid-induced constipation and emesis in cancer patients.
    Ishihara M; Iihara H; Okayasu S; Yasuda K; Matsuura K; Suzui M; Itoh Y
    Support Care Cancer; 2010 Dec; 18(12):1531-8. PubMed ID: 19921282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic and clinical burden of opioid-induced nausea and vomiting.
    Nicholson BD
    Postgrad Med; 2017 Jan; 129(1):111-117. PubMed ID: 27690715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study on the antiemetic effect and extrapyramidal symptoms of prochlorperazine versus perospirone for the control of nausea and vomiting due to opioid introduction].
    Yomiya K; Takei D; Kurosawa H; Kono B
    Gan To Kagaku Ryoho; 2013 Aug; 40(8):1037-41. PubMed ID: 23986047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preventive therapy for nausea and vomiting in patients on opioid therapy for non-malignant pain in rheumatology].
    Scotto di Fazano C; Vergne P; Grilo RM; Bertin P; Bonnet C; Trèves R
    Therapie; 2002; 57(5):446-9. PubMed ID: 12611198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Prophylactic Ondansetron with Intravenous Opioids in Emergency Department Patients: A Prospective Observational Pilot Study.
    Culver MA; Richards EC; Jarrell DH; Edwards CJ
    J Emerg Med; 2017 Nov; 53(5):629-634. PubMed ID: 28987314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic metoclopramide is unnecessary with intravenous analgesia in the ED.
    Talbot-Stern J; Paoloni R
    Am J Emerg Med; 2000 Oct; 18(6):653-7. PubMed ID: 11043615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multi-institutional study analyzing effect of prophylactic medication for prevention of opioid-induced gastrointestinal dysfunction.
    Ishihara M; Ikesue H; Matsunaga H; Suemaru K; Kitaichi K; Suetsugu K; Oishi R; Sendo T; Araki H; Itoh Y;
    Clin J Pain; 2012 Jun; 28(5):373-81. PubMed ID: 22156893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of nausea and vomiting in pain medication for digestive cancer].
    Yamada T; Kanazawa Y; Uchida E; Yokoi K
    Gan To Kagaku Ryoho; 2012 Oct; 39(10):1517-21. PubMed ID: 23064063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of antiemetics in the management of chemotherapy-related nausea and vomiting in current UK practice.
    Molassiotis A; Brearley SG; Stamataki Z
    Support Care Cancer; 2011 Jul; 19(7):949-56. PubMed ID: 20574666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of opioid-induced nausea and vomiting].
    Hirakawa N
    Masui; 2013 Jul; 62(7):829-35. PubMed ID: 23905406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preliminary study of the effect of naldemedine tosylate on opioid-induced nausea and vomiting.
    Sato J; Tanaka R; Ishikawa H; Suzuki T; Shino M
    Support Care Cancer; 2020 Mar; 28(3):1083-1088. PubMed ID: 31183560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of Opioid-Induced Nausea and Vomiting During Treatment of Moderate to Severe Acute Pain: A Randomized Placebo-Controlled Trial Comparing CL-108 (Hydrocodone 7.5 mg/Acetaminophen 325 mg/Rapid-Release, Low-Dose Promethazine 12.5 mg) with Conventional Hydrocodone 7.5 mg/Acetaminophen 325 mg.
    Zuniga JR; Papas AS; Daniels SE; Patrick K; Muse DD; Oreadi D; Giannakopoulos HE; Granquist EJ; Levin LM; Chou JC; Maibach H; Schachtel BP
    Pain Med; 2019 Dec; 20(12):2528-2538. PubMed ID: 30657996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating the efficacy and safety of olanzapine prophylaxis for opioid-induced nausea and vomiting (JORTC-PAL20): a study protocol for an open-label, single-arm exploratory study.
    Satomi E; Kobayashi T; Ishikawa A; Arakawa S; Ishiki H; Amano K; Sakiyama N; Ariyoshi K; Kihara K; Oyamada S; Mizushima A
    BMJ Open; 2024 Feb; 14(2):e076575. PubMed ID: 38417963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.